New Market Report: Case Study: Personalized Cancer Therapy - Anticipated competition threatens to dampen commercial potential of new approvals
The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.
View full press release